Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TLC Vita OB Capsule
- Development stage
- Unknown
- Lead developer
- Remed Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
TLC Vita OB Capsule is an oral prenatal multivitamin and anti-anemic supplement developed by Remed Pharmaceuticals (acquired by MOHS Analytics) and manufactured by Scheele Laboratories Phils. It is formulated with ferrous fumarate, folic acid, vitamin B-complex (including vitamins B1, B2, B3, B5, B6, and B12), and vitamin C. The supplement is indicated for the prevention and treatment of iron-vitamin and dietary deficiency anemias, particularly during pregnancy, lactation, or following blood loss from menstruation, surgery, or delivery.
- Brand names
- TLC Vita OBTLC Vita OB CapsuleTLC Vita-OBTLC Vita-OB Capsule
- Other names
- multivitamins + ferrous fumaratemultivitamins + iron
02
Targets
TFRC (Transferrin Receptor)
Beyond the preview
Go deeper on TLC Vita OB Capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TLC Vita OB Capsule.